Nucleai alternatives and competitors
The closest alternatives to Nucleai are Modella AI, Valar Labs, PictorLabs and Aignostics.
Tissue intelligence company for drug development, applying computer vision and machine learning to H&E, immunohistochemistry, multiplex imaging and spatial transcriptomics and linking tissue features to clinical outcomes.
10 alternatives to Nucleai
What each product does, with its price as the vendor publishes it.
-
M
Boston biomedical AI company, acquired by AstraZeneca, building generative and agentic tools for pathology.
Price: Research use only, not commercially priced for clinical use
-
V
Valar Labs is a precision oncology company, founded in 2021, whose tests predict treatment response and prognosis from routine H and E slides using its Computational Histology AI platform, trained on more than 500,000 pathologist annotations.
-
P
PictorLabs, which now styles its name Pictor Labs, makes software that stains tissue images with AI instead of chemicals, and a tissue intelligence platform built on it.
Price: No published price
-
A
Aignostics builds foundation models for computational pathology and sells them, and applications built on them, to biopharmaceutical companies for target discovery, translational research, clinical trials and companion diagnostic development, and to pathology laboratories under research use terms.
Price: No published price
-
B
Biomy makes DeepPathFinder, cloud software that uses AI to map immune and cancer cells on tissue slides for drug research.
Price: No published price
-
B
Bioptimus is a Paris company that builds AI foundation models for pathology and biology. Drug companies, research groups and pathology software makers license them as a base for their own tools.
Price: No published price
-
V
Visiopharm sells pathology image analysis software for diagnostics and research, with its diagnostic products packaged as APPs: deep learning algorithms that score HER2, Ki67, ER and PR and detect metastases in breast cancer, score PD-L1 in non-small cell lung cancer, and assess prostate…
Price: No published price
-
D
Deciphex is a Dublin company founded in 2017 by Donal O'Shea, its chief executive, addressing the shortage of pathologists.
Price: No published price
-
P
PathAI sells AISight, a cloud image management system that anatomic pathology laboratories use to manage cases, read slides on screen and run AI, along with its own algorithms and a menu of partner algorithms.
Price: No published price
-
P
Panakeia infers molecular status from routine H&E slide images, without sequencing, immunohistochemistry or additional tissue.
Price: No pricing published; clinical products and research platform both quoted, unit of charge unstated
Nucleai alternatives, answered
What are the best alternatives to Nucleai?
The closest alternatives to Nucleai are Modella AI, Valar Labs, PictorLabs, Aignostics and Biomy. Valar Labs is a precision oncology company, founded in 2021, whose tests predict treatment response and prognosis from routine H and E slides using its Computational Histology AI platform, trained on more than 500,000 pathologist annotations. PictorLabs, which now styles its name Pictor Labs, makes software that stains tissue images with AI instead of chemicals, and a tissue intelligence platform built on it. Aignostics builds foundation models for computational pathology and sells them, and applications built on them, to biopharmaceutical companies for target discovery, translational research, clinical trials and companion diagnostic development, and to pathology laboratories under research use terms.
Who are Nucleai's competitors?
Nucleai's competitors in the Digital Pathology AI category include Modella AI, Valar Labs, PictorLabs, Aignostics, Biomy and Bioptimus.